Abbott is a distinguished global leader in the healthcare sector, renowned for its suite of life-changing health technologies. Founded in 1944, the company has solidified its presence across multiple industries, including Biotechnology, Health Care, Manufacturing, Medical Devices, Nutrition, and Pharmaceuticals.
With its headquarters in the United States, Abbott commands a broad geographical footprint, delivering innovative healthcare solutions to consumers in over 160 countries. Their impressive talent pool, comprising 122,000 colleagues, ensures a dynamic and adaptable workforce.
In terms of investment, Abbott received their last known funding—an infusion of $100.00K in Post IPO Debt—on 01 March 2011. Despite the time since its last funding, the company's longstanding history and multifaceted industry involvement highlight its potential stability and continuous innovations, positioning it as a lucrative prospect for investors seeking a stronghold in the healthcare space.